Inflammation

6 Items

per page
Set Descending Direction
  1. anti-Angiopoietin-2 (human), mAb (rec.) (blocking) (Angy-1-4) (preservative free)
    AG-27B-0015PF
    AG-27B-0015PF-C100100 µg
    CHF 420.00
    AG-27B-0015PF-C500500 µg
    CHF 1'140.00
    AG-27B-0015PF-M0011 mg
    CHF 2'040.00
    Structure of the recombinant antibody anti-Angiopoietin-2 (human), mAb (rec.) (blocking) (Angy-1-4) (preservative free) (Prod. No. AG-27B-0015PF). The single chain variable human fragment (ScFv) selected by antibody phage display technology and specific t
  2. anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1)
    AG-27B-0016
    AG-27B-0016-C100100 µg
    CHF 420.00
    Structure of the recombinant antibody anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (Prod. No. AG-27B-0016). The single chain variable human fragment (ScFv) selected by antibody phage display technology and specific to the antigen of interest is f
  3. anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (preservative free)
    AG-27B-0016PF
    AG-27B-0016PF-C100100 µg
    CHF 420.00
    AG-27B-0016PF-C500500 µg
    CHF 1'140.00
    AG-27B-0016PF-M0011 mg
    CHF 2'040.00
    Structure of the recombinant antibody anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (preservative free) (Prod. No. AG-27B-0016PF). The single chain variable human fragment (ScFv) selected by antibody phage display technology and specific to the an
  4. anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
    AG-20B-6001YPF
    AG-20B-6001YPF-C100100 µg
    CHF 290.00
    AG-20B-6001YPF-C500500 µg
    CHF 730.00
    Replaces AG-20B-6001PF
    anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
  5. anti-Periostin, mAb (blocking) (OC-20) (preservative free)
    AG-20B-6000YPF
    AG-20B-6000YPF-C100100 µg
    CHF 470.00
    AG-20B-6000YPF-C500500 µg
    CHF 1'900.00

    Replaces AG-20B-6000PF

    anti-Periostin, mAb (blocking) (OC-20) (preservative free)

6 Items

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.